FSD Pharma Inc. (HUGE)
0.09
-0.01 (-10.00%)
At close: Aug 14, 2024, 8:00 PM
-10.00% (1D)
| Bid | n/a |
| Market Cap | 66.67K |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -13.14M |
| EPS (ttm) | -16.25 |
| PE Ratio (ttm) | -0.005532307692307692 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 22,015,006 |
| Avg. Volume (20D) | 196,163 |
| Open | 0.10 |
| Previous Close | 0.10 |
| Day's Range | 0.09 - 0.10 |
| 52-Week Range | 0.09 - 109.19 |
| Beta | 0.85 |
About HUGE
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such as depressive disorder; and Lucid-MS, a patented new chemical entity shown to prevent and reverse myel...
Sector Healthcare
IPO Date Jun 8, 2018
Employees 17
Stock Exchange NASDAQ
Ticker Symbol HUGE
Website https://www.fsdpharma.com
8 months ago
+120.71%
FSD Pharma shares are trading higher after Celly N...
Unlock content with
Pro Subscription
11 months ago
-3.26%
Shares of cannabis stocks are trading higher after Biden said the Justice Department is taking the next steps to reclassify marijuana from Schedule I to Schedule III.